St. Jude Medical paid about $123 million to acquire a developer of small, leadless cardiac pacemakers not yet approved in the U.S. The deal follows St. Jude's 2011 recall of leads for two of its pacemakers.
The deal with Nanostim, an early-stage medical-device company based in Milpitas, Calif., has been in the works for several years.
Read more »
The government shutdown isn't stopping Food and Drug Administration advisory committee meetings scheduled this month, according to drug and device manufacturers.
Some analysts warned that the shutdown could limit the FDA's panel discussions, postpone meetings and ultimately delay product launches and spook investors.
Read more »
Have you heard this joke before?
How do you know when a total joint implant sales rep is at the hospital? When the orthopedic surgeons' cars aren't the nicest ones in the parking lot.
Read more »
